Matches in Wikidata for { <http://www.wikidata.org/entity/Q85034775> ?p ?o ?g. }
Showing items 1 to 69 of
69
with 100 items per page.
- Q85034775 description "article scientifique publié en 2010" @default.
- Q85034775 description "artículu científicu espublizáu en setiembre de 2010" @default.
- Q85034775 description "im September 2010 veröffentlichter wissenschaftlicher Artikel" @default.
- Q85034775 description "scientific article published on 16 September 2010" @default.
- Q85034775 description "wetenschappelijk artikel" @default.
- Q85034775 description "наукова стаття, опублікована у вересні 2010" @default.
- Q85034775 name "The Italian Society of Gastroenterology (SIGE) and the Italian Group for the study of Inflammatory Bowel Disease (IG-IBD) Clinical Practice Guidelines: The use of tumor necrosis factor-alpha antagonist therapy in inflammatory bowel disease" @default.
- Q85034775 name "The Italian Society of Gastroenterology (SIGE) and the Italian Group for the study of Inflammatory Bowel Disease (IG-IBD) Clinical Practice Guidelines: The use of tumor necrosis factor-alpha antagonist therapy in inflammatory bowel disease" @default.
- Q85034775 type Item @default.
- Q85034775 label "The Italian Society of Gastroenterology (SIGE) and the Italian Group for the study of Inflammatory Bowel Disease (IG-IBD) Clinical Practice Guidelines: The use of tumor necrosis factor-alpha antagonist therapy in inflammatory bowel disease" @default.
- Q85034775 label "The Italian Society of Gastroenterology (SIGE) and the Italian Group for the study of Inflammatory Bowel Disease (IG-IBD) Clinical Practice Guidelines: The use of tumor necrosis factor-alpha antagonist therapy in inflammatory bowel disease" @default.
- Q85034775 prefLabel "The Italian Society of Gastroenterology (SIGE) and the Italian Group for the study of Inflammatory Bowel Disease (IG-IBD) Clinical Practice Guidelines: The use of tumor necrosis factor-alpha antagonist therapy in inflammatory bowel disease" @default.
- Q85034775 prefLabel "The Italian Society of Gastroenterology (SIGE) and the Italian Group for the study of Inflammatory Bowel Disease (IG-IBD) Clinical Practice Guidelines: The use of tumor necrosis factor-alpha antagonist therapy in inflammatory bowel disease" @default.
- Q85034775 P1433 Q85034775-3E448B9B-2921-46AB-A4E8-198EA97373FD @default.
- Q85034775 P1476 Q85034775-AA882C21-F68A-4CC9-B378-11126752F58C @default.
- Q85034775 P2093 Q85034775-29A0FF4D-63AC-4BA4-A7E0-D6A2C3D46FA6 @default.
- Q85034775 P2093 Q85034775-37A1D045-D2D0-4C35-BE1A-5A0A4F7F4763 @default.
- Q85034775 P2093 Q85034775-8DC60D8B-111E-4326-88D8-49DCB66CD1C2 @default.
- Q85034775 P2093 Q85034775-96E962D3-5DEE-4514-93B2-D89EEFFBAF63 @default.
- Q85034775 P2093 Q85034775-A41AEB46-EA8F-4A6F-A617-D528DF137C53 @default.
- Q85034775 P2093 Q85034775-A88C6890-EC38-4203-B61D-868D24B2CA47 @default.
- Q85034775 P2093 Q85034775-B312457D-76BE-4E94-955A-3D2FA382766B @default.
- Q85034775 P2093 Q85034775-B72542B1-333A-4436-83FD-7DBB111939A7 @default.
- Q85034775 P2093 Q85034775-B7CA5DD5-3947-4C30-B1A3-A9020FC585C9 @default.
- Q85034775 P2093 Q85034775-C1CA2963-C0EE-43EF-810E-7695C084DCE5 @default.
- Q85034775 P2093 Q85034775-D890477D-6308-40A8-AE3F-6D3695AC500D @default.
- Q85034775 P2093 Q85034775-E03CAC06-3A65-401A-B37F-45C18A3F3B9F @default.
- Q85034775 P2093 Q85034775-E33D5513-79A7-47C9-80A6-603417F481AE @default.
- Q85034775 P304 Q85034775-ED36389B-E012-4A6C-8A26-539B9D0A79CD @default.
- Q85034775 P31 Q85034775-E86955DE-9C49-4D12-9E32-8C2237858FA6 @default.
- Q85034775 P356 Q85034775-A2864E24-DE9B-4A55-B936-132309EED211 @default.
- Q85034775 P433 Q85034775-8B8DC064-6742-43F1-A798-7972C26699AC @default.
- Q85034775 P478 Q85034775-35410452-FC78-4660-8DD0-3D33A36D13C1 @default.
- Q85034775 P50 Q85034775-3832F9E9-080A-4102-8988-F2FC0F4B3062 @default.
- Q85034775 P50 Q85034775-45974FB0-F5CC-4E08-8615-8F2E07E0D90F @default.
- Q85034775 P50 Q85034775-8908FA77-E35E-4EC7-9796-2D2F7C29F69B @default.
- Q85034775 P50 Q85034775-93BA8AFA-602C-4635-BED6-504783C3A835 @default.
- Q85034775 P577 Q85034775-508F3285-E0A6-4E35-A664-B54311AB7368 @default.
- Q85034775 P698 Q85034775-201FD173-8377-4DD7-B101-658D3919575E @default.
- Q85034775 P921 Q85034775-D665E42F-7B6E-4535-878D-B76F401FDBA2 @default.
- Q85034775 P356 J.DLD.2010.07.010 @default.
- Q85034775 P698 20843756 @default.
- Q85034775 P1433 Q15766194 @default.
- Q85034775 P1476 "The Italian Society of Gastroenterology (SIGE) and the Italian Group for the study of Inflammatory Bowel Disease (IG-IBD) Clinical Practice Guidelines: The use of tumor necrosis factor-alpha antagonist therapy in inflammatory bowel disease" @default.
- Q85034775 P2093 "Alessandro Armuzzi" @default.
- Q85034775 P2093 "Ambrogio Orlando" @default.
- Q85034775 P2093 "Anna Kohn" @default.
- Q85034775 P2093 "Aurora Bortoli" @default.
- Q85034775 P2093 "Claudio Papi" @default.
- Q85034775 P2093 "Fabiana Castiglione" @default.
- Q85034775 P2093 "Gilberto Poggioli" @default.
- Q85034775 P2093 "Italian Group for the study of Inflammatory Bowel Disease" @default.
- Q85034775 P2093 "Italian Society of Gastroenterology" @default.
- Q85034775 P2093 "Livia Biancone" @default.
- Q85034775 P2093 "Maurizio Vecchi" @default.
- Q85034775 P2093 "Renata D'Incà" @default.
- Q85034775 P2093 "Vito Annese" @default.
- Q85034775 P304 "1-20" @default.
- Q85034775 P31 Q13442814 @default.
- Q85034775 P356 "10.1016/J.DLD.2010.07.010" @default.
- Q85034775 P433 "1" @default.
- Q85034775 P478 "43" @default.
- Q85034775 P50 Q38324765 @default.
- Q85034775 P50 Q54867164 @default.
- Q85034775 P50 Q57069528 @default.
- Q85034775 P50 Q57131172 @default.
- Q85034775 P577 "2010-09-16T00:00:00Z" @default.
- Q85034775 P698 "20843756" @default.
- Q85034775 P921 Q917447 @default.